Trefoil peptides represent a family of small stable molecules bearing a three-loop trefoil structure formed by three intrachain disulfide bonds (1, 2) . Three members of this family have been identified in humans: pS2 (trefoil factor 1: TFF1), spasmolytic polypeptide (SP: TFF2), and intestinal trefoil factor (ITF: TFF3). They share a highly conserved motif (CX 9 CX 9 CX 4 CX 9 WCF), comprised of six conserved cysteine residues responsible for the trefoil motif formation. PS2 and ITF also form homodimers and heterodimers with different degree of glycosylation, and these modifications may be of functional significance (3) . The trefoil peptides are involved in mucosal healing processes and are expressed at abnormal elevated levels in neoplastic diseases (4 -14) . A wide range of human carcinomas and gastrointestinal inflammatory malignancies, including peptic ulceration and colitis, Crohn's syndrome, pancreatitis, and biliary disease, aberrantly express trefoil peptides (10 -12) . The trefoil peptide pS2 is a breast cancer-associated secreted protein of 60 amino acids that is transcriptionally induced by estrogens in the mammary carcinoma cell line MCF-7 (13, 14) . In the antrum of the normal stomach, pS2 is intimately associated with mucus secretions (15, 16) and is regulated by a variety of factors including estrogens, epidermal growth factor (EGF), tumor promoter TPA, and the c-Ha-ras oncogene (17) . PS2 expression is closely associated with premalignant stages in human gastric carcinoma (18) and with the neuroendocrine differentiation of prostate cancers, via an estrogen-independent pathway (11, 12) . In agreement, pS2 was negative in patients with benign prostate hyperplasia, whereas 92% of patients at risk with prostate cancer are positive for pS2 expression (19) .
One of the early events in inflammation and wound healing is the epithelial restitution of the digestive mucosa, which is tightly related to cell proliferation, migration, and a risk/benefit balance between anti-apoptotic and proapototic signals in response to mucosal injury by cellular and DNA damaging agents such as cytokines, free radicals, and nitric oxide. In animal models, trefoil peptides are essential participants of mucosal repair in inflammation and wound healing (5) (6) (7) 9) . They are considered as morphogen regulatory peptides (20, 21) . Intestinal trefoil peptide also confers colonic epithelial resistance to apoptosis, because transgenic mice deficient in ITF showed an increase in colonocyte apoptosis unaccompanied by changes in expression of receptor-related (TNF-R/Fas) or stressrelated (Bcl-family) cell death regulators (22) . However, our actual knowledge on the signaling pathways activated by the putative TFF receptors or recognition sites from the cell surface to the cytoplasm and nucleus is still very incomplete. Recent studies designated the possible contribution of EGF receptors, MAPK, and APC/E-cadherin/␤-catenins as downstream elements involved in trefoil peptide signals, leading to decreased cell-cell and cell-substratum adhesion (23) (24) (25) (26) .
In view of the critical role of the TFFs in the regulation of epithelial cell migration and their possible action on signaling pathways involved in cell adhesion and transformation, we investigated the role TFFs play in regulating tumor progression and invasion. To determine whether such an effect might be relevant to disease, we used colonic and kidney epithelial cell lines at various stages of the neoplastic transformation controlled by the src oncogene and the human colonic cell line HCT8/S11 established from a sporadic tumor (27) (28) (29) . The signaling activity of pS2, SP, and ITF was examined with reference to possible connections with several cellular invasion pathways (30 -32) , namely, PI3Ј-K, Rho-like G-proteins, and protein kinase C (PKC). Evidence is provided that TFFs can regulate cell transformation and neoplastic progression in two ways, by inducing cell scattering and invasion of basement membranes.
MATERIALS AND METHODS

Reagents
Clostridium botulinum exoenzyme C3 transferase (abbreviated C3T), which ADP-ribosylates and inactivates the small GTPase RhoA, and hepatocyte growth factor/scatter factor (HGF) were generous gifts from Dr. Gilles Flatau (INSERM U452, Nice, France) and Pr. Paolo Comoglio (University of Turin, Italy), respectively. Leptin was from R&D Systems Europe Ltd. (Oxon, U.K.). Wortmannin (WORT), U-73122, Gö6976 (a selective inhibitor of PKC␣ and PCK␤ I isoenzymes that has no effect on the atypical Ca 2ϩ -independent PKCs), and GF109203X (abbreviated GF109), a PKC inhibitor with high selectivity for PKC␣, ␤I, ␤II, ␥, and ε isoenzymes were from Calbiochem (Meudon, France). Forskolin (FK), pertussis toxin (PTx), rapamycin, and phenylmethysulfonyl fluoride (PMSF) were from Sigma (Saint-Quentin Fallavier, France). Collagen type I was from Upstate Biotechnology (Lake Placid, N.Y.).
Cell lines and tissue samples from human gastrointestinal tumors
Parental Madin-Darby canine kidney epithelial cells MDCK were a generous gift from Dr. J. Downward (Imperial Cancer Research Fund, London, U.K.). MDCKts.src transformed by a temperature-sensitive mutant of v-src (MDCKts.src, Cl2) and the MDCKts.src-p110DN cell line (transfected with the dominant negative mutant p110 ␣ EcoS of PI3Ј-K) were previously described (27, 30) . The human embryonic kidney cell line HEK-293T and MDCKT23 cells expressing the mutant Gproteins RhoAV14, RhoAN19, or Rac1V12 under the tetracycline-repressible transactivator were generous gifts from Dr. Silvio Gutkind (NIH, Bethesda, Md.) and Dr. J. Nelson (33), respectively. Expression of V14RhoA and V12Rac1 was induced in MDCKT23 cells by removing doxycycline (DOX, Sigma) for 16 -18 h (V14RhoA and V12Rac1) or 40 h (N19RhoA) from the culture media (33) .
Human colorectal cell lines HCT-8/S11, HCT-8/S11/R1, PC/AA/C1, and PCmsrc were routinely grown in 6 cm diameter Petri dishes, as described previously (28, 29) . The PC/AA/C1 cell line was established from a colonic adenoma in a patient with familial adenomatous polyposis (FAP). This cell line is nontumorigenic and exhibits a mucinous phenotype. After transfer of the activated c-src oncogene, PCmsrc cells became tumorigenic in the athymic nude mice and were invasive upon addition of HGF (28) . Human breast cancer cells MCF-7 were cultured as described (34) .
Specimens from patients who had undergone surgery for gastric or colonic cancers were obtained from the Center de Chirurgie Digestive (Prof. R. Parc, Hôpital Saint-Antoine, Paris, France), as described previously (35) . Tissue samples from 0.5 to 3 g were snap-frozen in liquid nitrogen and stored at Ϫ80°C until use. For each tumor, a frozen section was subjected to histological analysis, to confirm the neoplastic origin of the sample. Colonic adenocarcinomas (ADK) were sampled in the infiltrating area of tumors. In each case, the corresponding control mucosa was dissected out from the tumor and analyzed as paired control tissue with normal histological architecture. Tissues for immunohistochemical analyses of pS2 were fixed in neutral-buffered formalin and embedded in paraffin wax.
Construction and validation of the pcDNA3-hpS2 expression plasmid
The hpS2 cDNA fragment (462 bp) was excised from the pGEM1 plasmid (13) by EcoRI/BamHI digestion and cloned in frame into the eukaryotic expression vector pcDNA3 recombined with the neo-resistance gene (InVitrogen, Groningen, The Netherlands). The new plasmid construct was named pcDNA3-hpS2. After transforming into Escherichia coli (MC106/P3 strain, InVitrogen), pcDNA3-hpS2 was prepared with mini-prep and identified by an assay of restriction enzyme digestion. The structure and function of pcDNA3-hpS2 was checked by direct DNA sequencing and expression in HEK-293T cells. Transient transfection of HEK-293T cells in 10 cm plates was performed using 2 g of pcDNA3-hpS2 expression plasmid and the LipofectAMINE Plus method (Gibco BRL, Cergy Pontoise, France), according to the manufacturer's protocol. After 6 h incubation at 37°C in a humidified atmosphere of 5% CO 2 in air, the transfection mixture was replaced with new medium. Transfected cells were then cultured in standard conditions for an additional 48 h period, prior to assay for hpS2 expression by Western blotting.
Stable transfection of colonic and kidney epithelial cells by the hpS2 cDNA
MDCKts.src cells and HCT-8/S11 cells were stably transfected by the human full-length hpS2 cDNA in the pcDNA3-hpS2 expression plasmid using the LipofectAMINE Plus reagent. Control transfections were performed using the empty vector pcDNA3. Cultures were selected in 1 mg/ml neomycin (Gibco BRL) for 2 wk and resistant colonies were ring-cloned as individual colonies or pooled for hpS2 analysis by immunoblotting and further functional characterization.
Preparation of recombinant trefoil factors
Human SP and ITF were produced in yeast and purified as described (36, 37) , recombinant hpS2 produced in E. coli was purified by affinity chromatography (38) .
Western blot analyses and immunohistochemistry for hpS2
For immunoblotting, cultured cells were homogenized at 4°C in RIPA buffer containing 0.1 mg/ml PMSF, 100 M benzamidine, and 100 mM Na3VO4 as protease inhibitors. Frozen tissues from human gastrointestinal tumors were disrupted in ice-cold 10 mM Tris-HCl (pH 7.5) containing 1% Nonidet P-40, 150 mM NaCl, 10% glycerol, 50 mM NaF, 5 mM EDTA, 1 mM EGTA, 0.2 mM orthovanadate, 0.2 mM PMSF, 10 mg/ml each of leupeptin, and aprotinin. A Polytron apparatus was used, with three bursts of 15 s. Insoluble material was removed by centrifugation for 15 min at 4°C and 12,000 g. Proteins were resolved in nonreducing conditions in 15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to Hybond-P Extra membranes (Pharmacia Biotech, Buckinghamshire, England). Membranes were blocked in Tris-buffered saline (TBS: 20 mM Tris-HCl, pH 8, 150 mM NaCl) containing 5% dried skimmed milk. The blots were then incubated in blocking solution for 1 h at 25°C and overnight with the mAb p2802 (dilution: 1/100). The anti-pS2 monoclonal antibody (mAb p2802) raised against the carboxyl-terminal domain of pS2 was previously described (39) . Membranes were washed in TBS containing 0.1% Tween 20, probed with a goat anti-mouse immunoglobulin G polyclonal antibody (1/2000, Santa Cruz Biotechnologies, Santa Cruz, Calif.), and revealed by enhanced chemiluminescence Western detection (ECL, Amersham, Saclay, France). Tissue sections from a sigmoid ADK (stage D), including the primary colorectal tumor and adjacent mucosa, were stained for hpS2 with mAb p2802 (1:40 dilution) and revealed by LSAB (linked streptavidin biotin) and peroxidase.
Collagen invasion and cell scattering assays
For invasion of collagen gels by renal and intestinal epithelial cells, Petri dishes were filled with 1.35 ml of neutralized type I collagen and incubated overnight at 37°C to allow gelling. Cells were harvested using Moscona buffer and trypsin/ EDTA, and seeded on top of the collagen gels. Cultures were incubated for 24 h at the indicated temperature in the presence or absence of TFF alone or combined with appropriate inhibitors of signal transduction pathways. The depth of cell migration inside the gels was measured using an inverted microscope (40) . Invasive and superficial cells were counted in 12 fields of 0.157 mm 2 . The invasion index is the percentage of cells invading the gel over the total number of cells.
For cell scattering, MDCKts.src Cl2 cells were seeded at 40°C in 24-well plates at the density of 2 ϫ 10 4 cells and treated for 4 h with 0.1 M each of hSP and hITF. The cell scattering was monitored under an inverted phase-contrast microscope.
RESULTS
Collaboration between TFFs and RhoA for collagen invasion by premalignant colonic and kidney epithelial cells
We first sought to determine whether nontumorigenic epithelial cells could be induced to invade collagen gels in response to exogenous TFFs. As shown in Fig. 1A , the trefoil peptides pS2, SP, and ITF (at 0.1 M) and scatter factor HGF (10 U/ml) are not competent for inducing cellular invasion by the premalignant human colonic cell line PC/AA/C1 established from a polyp in a patient with FAP. As a positive control, we show that leptin (100 ng/ml) promotes invasion in PC/AA/C1 epithelial cells, as described (41 
Collaboration between TFFs and src for collagen invasion by colonic and kidney epithelial cells
Activation of the src oncogene has been reported to be frequently associated with premalignant colon adenomatous mucosa. C-Src kinase activity is known to modulate cell spreading, migration, and invasion in many cell types (28, 42) . Increased c-src protein expression and activating mutations in the carboxyl-terminal regulatory region of this nonreceptor tyrosine kinase are the critical molecular defects involved in src activation and colon cancer progression (43, 44) . Two steps of src activation take place during colonic carcinogenesis: one in the polyps and primary tumors, and a second, greater increase in liver metastases (45) , suggesting a potential role for src in local and distant invasion. As shown in Fig. 2A , activation of src in PCmsrc cells (28) is not sufficient to induce the invasive phenotype in collagen gels. This invasive property was induced by the scatter factor HGF, the natural ligand of the Met oncogene, a tyrosine kinase receptor that is overexpressed and amplified during the progression of colorectal cancer (46) . The trefoil factor ITF (0.1 M) mimicked the HGF-induced invasiveness of PCmsrc cells, and this effect was abolished by the PI3Ј-K inhibitor wortmannin (10 nM, WORT). Inhibiting RhoA by C3 exotransferase (C3T, 3 g/ml), thereby converting it to a dominant interfering form (47), leads to a loss of ITF-induced invasion in PCmsrc cells. We conclude that the downstream activation of Rho contributes to the invasive phenotype of PCmsrc cells induced by TFFs, as suggested in Fig. 1 for the permissive interactions between Rho and ITF signals in MDCK cells transfected with the activated form of RhoA. These observations are consistent with RhoA and src playing a critical role as a signal transducers in the multiple signaling pathways emerging from focal adhesion complexes, cellcell contacts, and leading to the coordinated reorganization of the actin/myosin network by growth factor receptors during cell migration and invasion. C3T toxin treatment of MDCKts.src cells inhibited by 90% the invasion of collagen gels induced by src activation at 35°C (data not shown), suggesting that RhoA is implicated in the recruitment and activation of src at the 
and internalization in the endosomal compartment were also found (48, 49) .
Because the PLC and PKC cascade has been shown to activate Rho (50, 51), we next investigated the effects of pharmacological inhibitors of these signal transduction elements. As shown in Fig. 2A , the two PKC inhibitors GF109203X (GF109, 1 M; Gö6976, 1 M) as well as persistent activation and down-regulation of PKC by 100 ng/ml TPA for 24 h prevented the ITF-induced invasion in PCmsrc cells. In contrast, ITF-induced cellular invasion was not reversed by PTx (100 ng/ml) or FK (10 M). These results imply that the signaling pathways activated by TFFs are not connected with PTx-sensitive trimeric G-protein subunits, in contrast to our previous data on inhibition of HGF-and leptininduced invasiveness by PTx in PCmsrc and MDCKts.src cells (30, 41) . Alternatively, we presented evidence that the ITF-induced invasiveness of PCmsrc cells is insensitive to cAMP-inducing agents that increase adenylate cyclase activity directly (forskolin) or indirectly via the ADP-ribosylation and neutralization of the Gi/Go subunits (pertussis toxin). Similar results were obtained with MDCKts.src cells, where invasion was induced by HGF and ITF (Fig. 2B) . Likewise, wortmannin, C3T, and PKC inhibitors neutralized ITFinduced invasion, whereas PTx or FK were ineffective. We also checked that stable expression of the dominant negative mutant PI3Ј-K in the MDCKts.src-p110DN cell line (30) abolished the ITF-induced invasion of collagen gels in this model (not shown).
Our data thus provide a new link between TFFdependent signaling and PI3Ј-K, PKC and Rho in the control of cellular invasion. PKC is composed of a family of serine-threonine kinases that plays an important role in tumor development and angiogenesis (52, 53) . As the PLC signaling pathway upstream PKC also regulates endothelial cell motility (54), it is clear that phospholipases C (PLC) are potentially involved in tumor invasion and progression toward the metastatic cascade. Consequently, we next examined whether invasiveness induced by trefoil peptides is sensitive to the PLC inhibitor U-73122. Treatment of MDCKts.src cells with 1 M U-73122 completely abolished the invasion of collagen gels induced by 100 nM of each TFF: pS2, SP, and ITF (data not shown). This pharmacological blockade is specific for the invasiveness induced by the TFFs because U-73122 had no effect on HGF-and leptin-induced invasion. Moreover, PLC isoforms ␤, ␥, and ␦ harbor pleckstrin homology PH domains responsible for appropriate membrane targeting and functionality regarding upstream signals activated by src and growth factor receptors. Most important, binding of PLC to plasma membrane via the PH domain is dependent on PI3Ј-K products such as PtdIns (3, 4, 5)-trisphosphate (55), suggesting interdependent activation and function between these two enzymes for definition of the invasive phenotype induced by TFFs in colonic and kidney epithelial cells. We next investigated the effect of various concentrations of the three trefoil peptides on invasion of collagen gels by PCmsrc and MDCKts.src cells.
Dose-dependent cellular invasion in response to the trefoil peptides
As shown in Fig. 3, pS2 , SP, and ITF dose-dependently stimulated invasion of collagen gels by colonic PCmsrc cells (Fig. 3A) and kidney epithelial cells MDCKts.src (Fig. 3B) . In the two models, very similar and parallel dose-response curves were observed for the three TFFs, with the same extent of maximal effect. Significant stimulation of invasion was observed in PCmsrc and MDCKts.src cells incubated in the presence of 10 nM SP or ITF (PϽ001). Half-maximal stimulation of invasion by SP and ITF was observed at similar concentra- tions (EC 50 ϭ20 -40 nM). Maximal stimulation induced by pS2, SP, and ITF represented a 10-fold increase of invasiveness above control.
Ectopic expression of full-length cDNA of human pS2 induced invasiveness in colonic HCT8/S11 and kidney MDCKts.src cells
Since our results indicate that exogenously added TFF peptides induce cellular invasion in our experimental models of src-and RhoA-transformed colonic and kidney epithelial cells, we next investigated the functional role of pS2, SP, and ITF on the invasive phenotype of human colon cancer cells established from a sporadic tumor. For this purpose, we engaged a study in colonic HCT8/S11 cells and their ␣-catenin-deficient counterparts, HCT8/S11R1 cells (29) . As shown in Fig.  4A , HCT8/S11R1 cells do not invade collagen gels in response to scatter factor, leptin, or any of the three TFFs tested. The functionality of the cell-cell junctional proteins involving E-cadherin and its associated cytoplasmic protein ␣-catenin is therefore a prerequisite for induction of the invasive phenotype in HCT8/ S11 cells vs. the S11R1 variant. Indeed, the three TFFs all induced strong invasiveness in HCT8/S11 cells (Fig.  4B) at levels similar to that observed in src-transformed colonic and kidney epithelial cells (Invasion indexϭ8 -10%), whereas HGF was ineffective. The TFF-induced invasion was completely blocked by rapamycin (10 nM) in HCT8/S11 cells. Rapamycin binds to FKBP12, this complex inactivates mTOR/FRAP and thus interferes with the activation of the PI3Ј-K/Akt/p70 S6 k/BAD signaling cascade that controls translation, cell growth and survival (56, 57) .
We next examined whether the constitutive overexpression of the pS2 protein, frequently observed in inflammatory conditions in the gastrointestinal tract, breast, and prostate cancers, is associated with induction of the invasive phenotype. We therefore expressed the pS2 cDNA in the TFF-competent colonic HCT8/ S11 and kidney MDCKts.src cell lines. The pcDNA3-hpS2 expression plasmid was functional because transiently transfected kidney HEK-293T.pS2 cells are positive for pS2 protein expression by SDS-PAGE and Western blot corresponding to identification of a prominent signal at ϳ9.6 kDa (data not shown). The same 9.6 kDa band was identified in two positive controls using a human gastric tumor and the MCF-7 breast cancer cell line. This expression vector was therefore used to establish constitutive expression of the pS2 protein in HCT8/S11 cells and MDCKts.src cells. Stably expressed transfectants were isolated by the selection using G418. Immunoblotting analysis specified three pS2-positive cell lines established from pcDNA3-hpS2-transfected HCT8/S11 cells (pool 1, clones 2 and 6), and three sublines were also isolated from pS2-transfected MDCKts.src cells (pool 2, clones 2 and 5). Mock-transfected colonic and kidney epithelial cells by using the empty pcDNA3 vector (pools 1 and 2) were negative for pS2 protein expression. Because pS2 is a secreted protein, we checked by Western blot that the conditioned culture medium by HCT/S11-pS2 (clone 2) and MDCKts.src-pS2 cells (clone 2) contained detectable amounts of the TFF (data not shown). In contrast, pS2 protein was not detected in the culture medium conditioned by nontransfected HCT8/S11 cells and mock-transfected MDCKts.src-pcDNA3 cells.
As shown in Fig. 5 , constitutive expression of the pS2 cDNA in HCT8/S11 cells (clone 2) and MDCKts.src cells (clone 2) resulted in induction of the invasive phenotype. Most important, the Rho inhibitor C3T failed to abolish the pS2-induced cellular invasion in both cell lines, suggesting that the persistent overexpression of pS2 may overcome or circumvent this blockade. Another possibility is that constitutive and deregulated expression of pS2 may initiate new invasion signals that are Rho independent. This interesting observation forms the basis of our work on new cellular invasion pathways and functions controlled by TFFs. In contrast, we found that pS2 overexpression was still sensitive to wortmannin (PI3Ј-K inhibitor), rapamycin, U-73122 (PLC inhibitor), was also abolished by PKC inhibitors, and remained insensitive to PTx and FK (Fig. 5A, B) . Our data therefore suggest that the constitutive overexpression of the pS2 protein during inflammatory processes or neoplastic progression may have a pathophysiological significance on autocrine Figure 4 . Role of the mTOR inhibitor rapamycin on trefoil peptide-induced invasion of collagen gels by HCT8/S11 and/S11R1 epithelial cells established from a human sporadic colonic tumor. Effect of HGF (10 units/ml), leptin (100 ng/ml), or the trefoil peptides pS2, SP, or ITF (100 nM) either alone or combined with rapamycin (10 nM) on invasion of collagen type I gels by human colonic epithelial cells HCT8/S11R1 (A) or HCT8/S11 (B). Data are means Ϯ se from 3 separate experiments. migration, restitution, and invasive properties of colonic and kidney mucosal cells.
Induction of cellular scattering by TFFs
Cell invasion is a major component of the complex multistep process of metastasis that is the most pejorative event linked to the development of fatal cancers. Acquisition of cell mobility and the capacity to invade basement matrix membranes and adjacent tissues play a central role in the adenoma-adenocarcinoma conversion and distant metastasis. To address whether TFFs have a motogenic activity in MDCKts.src cells, we examined cell scattering in MDCKts.src monolayer cultures incubated for 4 h in the presence or absence of SP and ITF. In control cultures, MDCKts.src cells incubated at 40°C formed tight colonies of adjacent epithelioid cells whereas the addition of 100 nM SP or ITF resulted in inhibition of cell-cell contacts, enhanced cellular motility, and induced scattering of the MDCKts.src cells (Fig. 6) . On the other hand, HGF/ scatter factor induced cell scattering, which is consistent with previous reports (58) .
Expression of pS2 in human colorectal tumors at various stages of the neoplastic progression
Using the monoclonal antibody p2802, we next examined the expression of the pS2 protein in human colorectal tumors and their adjacent nontransformed, histologically normal mucosa. We observe in Fig. 7A that pS2 exhibited a single broad immunoreactive band on SDS-PAGE, corresponding to ϳ9.6 kDa. This band was detected in all the samples examined, including colitis and early stages of the cancerous progression (adenoma, stages A and B of the Dukes' classification) and more advanced colonic tumors (C, D and liver metastases). One exception was Sample 40, i.e., the liver parenchyma (Liver) associated with a metastasis originating from a colonic tumor. Accordingly, immunochemical staining of pS2 in a human sigmoid tumor (stage D) revealed that expression of the pS2 protein is confined to mucin-secreting epithelial cells in both the tumorous sample and its corresponding adjacent control mucosa (Fig. 7B) . In this control sample, typical colonic epithelial crypts showed a normal architecture with marked pS2 accumulation restricted to the basal pole of the epithelial cells, in close proximity to the nucleus. Endothelial, inflammatory cells, and normal or tumor stroma were negative in tumor and control samples.
DISCUSSION
Our laboratories are interested in the identification of genetic and epigenetic factors involved in progression of digestive cancers, including 1) early and frequent cellular dysfunctions induced by src and ras oncogenes during the adenoma/adenocarcinoma conversion and 2) dietary factors, procarcinogens, inflammatory agents, and their associated molecular and cellular effectors.
A novel and important observation of the present study is the observation that the three trefoil peptides pS2, SP, and ITF induce invasion of collagen gels by kidney and colonic epithelial cells that are already engaged in the cancerous progression. Trefoil peptides may therefore exert a beneficial role on the restitution of injured digestive epithelia (2-6, 9, 21) or contribute to neoplastic progression in the human colon, depending on the normal or transformed status of the intestinal epithelial cells.
We have shown that TFFs are ineffective for inducing cellular invasion of premalignant colonic PC/AA/C1 and kidney MDCK epithelial cells and that src and Rho activation are required. The fact that TFFs need activated src/Rho signify that trefoil peptides do not activate these pathways efficiently, but need additional parallel and concomitant signals activating src/Rho. This condition is fulfilled by the frequent activation of src observed in early human colon cancers and can be also accomplished by RhoA activators such as lysophosphatidic acid and thrombin, two agents involved in inflammatory disorders, at the transition between preinvasive and invasive stages in the digestive tract.
To our knowledge, this is the first report that integrates the three TFFs in a comparative investigation on their biological effects and cell signaling in the context of the multistep process of tumorigenesis. These results have important implications for further studies on the involvement of TFFs as modulators of human digestive cancer growth and metastasis because we clearly identified pS2 in colitis, premalignant polyps, sporadic human colon cancers, and their liver metastases. In the normal gastrointestinal tract, the TFFs are expressed along the entire length of the gut, with pS2 and SP expressed primarily by the stomach (39, 59) and ITF by the goblet cells of small intestine and colon (60, 61) . No significant staining of pS2 was observed in a variety of human specimens from the normal colon, pancreas, liver, prostate, and kidney (39) . Mucosal ulceration in the duodenum and ileum induces pS2 and SP expression in the surrounding mucosa. Additional studies demonstrated intestinal pS2 expression in the ulcerassociated cell lineage in Crohn's disease (62) . Numerous clinical and experimental observations reveal that colonic cancer is increasingly frequent in inflammatory bowel disease. Our data support the notion that paracrine and autocrine TFF loops contribute to the transformed phenotype in colonic mucosa during inflammatory conditions, wound repair, and neoplastic progression. Furthermore, ITF also confers resistance to apoptosis in premalignant IEC and cancerous HT-29 intestinal epithelial cells (22) . Thus, TFFs apparently are implicated in beneficial and in beneficial effects for the gastrointestinal mucosal integrity during normal migration and healing of the injured digestive mucosa. Additional adverse effects for gastrointestinal TFFs should be considered in view of their ability to promote cell scattering and invasion of basement membrane matrix proteins during early human colon cancers initiated by activated src. Our data suggest an important role for pS2, SP, and ITF in cancer progression and provide a link between TFFs and signaling pathways regulating the reorganization of the cytoskeleton, focal adhesion as well as cellular motility and tumor invasion (30 -32, 63) .
Nevertheless, the important question concerns the molecular identity of the putative TFF binding sites or receptors involved in the initiation of multiple pathways linked to cellular invasion and matrix adhesion-dependent signaling and cell survival. Our data strongly suggest that the three TFFs interact with the same recognition sites mediating 1) both invasion and scattering, 2) similar parallel dose-response curves, and 3) connection with subsequent signaling cascades controlled by the same series of pharmacological inhibitors. The challenge will be to characterize the nature of these TFF recognition sites and their proximal downstream signaling elements. In the present study, we identified several signaling pathways playing a crucial role in the promotion of cellular invasion by TFFs. These include src/RhoA, PI3Ј-K/Akt, and phospholipase C/PKC, which are also activated by growth factor receptors, oncogenes, and are connected with the rapamycin-sensitive TOR cascade, leading to p70S6K activation. Targets of PI3Ј-K/Akt include BAD, an inhibitor of cell survival (57) . Identification of Cdc42 and Rac as regulators of p70S6K (56) provides further interplay and controls between TFFs and signaling cascades involved in tumor invasion, progression in the cell cycle, and apoptosis. Given the link between PI3Ј-K and the Rho family G-proteins, we present evidence here that MDCK cells are induced to invade collagen gels after activation of Rac, not by activated Rho. Similarly, premalignant adenomatous PC/AA/C1 cells that harbor an activated Ras allele (28) are not invasive in the presence of TFFs and become invasive after activation of src. Overexpression of pS2 cDNA confers constitutive induction of the invasive phenotype in stably transfected colonic HCT8-S11-pS2 cells that originate from a sporadic human colonic adenocarcinoma. Such a constitutive overexpression is observed here in premalignant colon adenoma, primary tumors, and their adjacent nontumorous mucosa. It is therefore likely that early and late colonic tumors may initiate distant induction of TFF in the histologically normal adjacent mucosa, which reflects a local inflammatory situation. Our data argue for autocrine, paracrine, and persistent deregulation of the TFF signals in premalignant and tumorous digestive mucosa characterized by a loss of mucosal polarity. The progressive accumulation of oncogenic defects, combined with constitutive activation of TFF secretion and signals during inflammatory bowel disease and neoplastic progression, can therefore generate subsequent aberrant cellular dysfunctions in initiated colonic epithelial cells.
As src activation is a frequent and early event in human colon cancer progression, TFFs fulfill the criteria to be regarded as scatter factors because of their involvement as modulators of cellular motility and invasion. Our findings shed new light on the relationships between trefoil factors and cancer progression as a general mechanism with broad significance for solid tumors concerned by TFF expression. Our data linking TFFs, cell invasion, and survival signaling pathways are prerequisite for developing novel combination therapies against colon cancer using new anti-invasion and -angiogenesis agents together with classical anti-cancer drugs (35, 64) . Further studies will bring more informations on TFF functions and signaling and how they interact with epithelial cells to control cellular migration and invasion during the renewal of the mucosa and progression of digestive cancers.
